# Artios Pharma

Source: https://onco.cc/companies/artios-pharma/  
OnCo record `artios-pharma` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Artios Pharma is a Cambridge, UK biotechnology company that leads two cancer trials in OnCo, testing its DNA damage response inhibitors ART0380 (ATR) and ART6043 (DNA polymerase theta) in advanced solid tumours.

## Summary

Artios Pharma Limited is a company based in Cambridge, United Kingdom (Wikidata Q140045444, which also gives its website). ClinicalTrials.gov classes it as an industry sponsor. It leads two phase 1/2a trials recorded in OnCo: NCT04657068, the ATR kinase inhibitor ART0380 alone and in combination (with gemcitabine, irinotecan or FOLFIRI) in advanced or metastatic solid tumours including ovarian, endometrial, colorectal and pancreatic cancer, and NCT05898399 (POLKA), the DNA polymerase theta inhibitor ART6043 alone and with olaparib in advanced solid tumours. Both compounds are its own, which is the basis for the biotech type.

## Fields

- Kind: Company
- Last checked: 2026-09-22
- Also known as: Artios Pharma Ltd; Artios Pharma Limited; Artios
- Tags: ctgov-sponsor; wave5-sponsor
- HQ: Cambridge
- Type: biotech
- Website: https://www.artios.com

## Sources

- Official website: https://www.artios.com
- Wikidata Q140045444: https://www.wikidata.org/wiki/Q140045444
- ClinicalTrials.gov: trials led by Artios Pharma Ltd: https://clinicaltrials.gov/search?lead=Artios%20Pharma%20Ltd

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Endometrial cancer](https://onco.cc/cancers/endometrial/), [Ovarian cancer](https://onco.cc/cancers/ovarian/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- targets: [ATR](https://onco.cc/targets/atr/)
- pathways: [DNA damage response & homologous recombination](https://onco.cc/pathways/ddr/)
- trials: [A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors](https://onco.cc/trials/nct04657068/), [Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)](https://onco.cc/trials/nct05898399/)

---
JSON: https://onco.cc/api/v1/entities/artios-pharma.json